• Je něco špatně v tomto záznamu ?

Gliomatosis cerebri in children: A poor prognostic phenotype of diffuse gliomas with a distinct molecular profile

G. Nussbaumer, M. Benesch, Y. Grabovska, A. Mackay, D. Castel, J. Grill, MM. Alonso, M. Antonelli, S. Bailey, JN. Baugh, V. Biassoni, M. Blattner-Johnson, A. Broniscer, A. Carai, GS. Colafati, N. Colditz, S. Corbacioglu, S. Crampsie, N....

. 2024 ; 26 (9) : 1723-1737. [pub] 20240905

Jazyk angličtina Země Anglie, Velká Británie

Typ dokumentu časopisecké články, multicentrická studie

Perzistentní odkaz   https://www.medvik.cz/link/bmc24018987

Grantová podpora
German- and Styrian Childhood Cancer Foundation
Etoile de Martin
Les Boucles du Cœur de la Fondation Carrefour
BB-033-00065 Necker Imagine Tumor and DNA biobank
Rudy A Menon Foundation
CRIS Cancer Foundation
Ollie Young Foundation
C13468/A23536 Cancer Research UK - United Kingdom
Joshua Bembo Project and the AYJ Fund
NHS
NIHR Great Ormond Street Hospital Biomedical Research Centre
PRIMUS/19/MED/06 Izas, la Princesa Guisante Foundation
Charles University Grant Agency
Fondazione Heal
Il Coraggio dei Bambini
Martina e La Sua Luna
Il laboratorio di Chiara
NET-2019-12371188 Regione Lombardia
Italian Ministry of Health
NET-2019-12371188 Regione Liguria

E-zdroje Online Plný text

NLK Free Medical Journals od 1999 do Před 1 rokem
PubMed Central od 1999 do Před 1 rokem
Europe PubMed Central od 1999 do Před 1 rokem
Open Access Digital Library od 1999-01-01
Medline Complete (EBSCOhost) od 2004-01-01 do Před 1 rokem

BACKGROUND: The term gliomatosis cerebri (GC), a radiology-defined highly infiltrating diffuse glioma, has been abandoned since molecular GC-associated features could not be established. METHODS: We conducted a multinational retrospective study of 104 children and adolescents with GC providing comprehensive clinical and (epi-)genetic characterization. RESULTS: Median overall survival (OS) was 15.5 months (interquartile range, 10.9-27.7) with a 2-year survival rate of 28%. Histopathological grading correlated significantly with median OS: CNS WHO grade II: 47.8 months (25.2-55.7); grade III: 15.9 months (11.4-26.3); grade IV: 10.4 months (8.8-14.4). By DNA methylation profiling (n = 49), most tumors were classified as pediatric-type diffuse high-grade glioma (pedHGG), H3-/IDH-wild-type (n = 31/49, 63.3%) with enriched subclasses pedHGG_RTK2 (n = 19), pedHGG_A/B (n = 6), and pedHGG_MYCN (n = 5), but only one pedHGG_RTK1 case. Within the pedHGG, H3-/IDH-wild-type subgroup, recurrent alterations in EGFR (n = 10) and BCOR (n = 9) were identified. Additionally, we observed structural aberrations in chromosome 6 in 16/49 tumors (32.7%) across tumor types. In the pedHGG, H3-/IDH-wild-type subgroup TP53 alterations had a significant negative effect on OS. CONCLUSIONS: Contrary to previous studies, our representative pediatric GC study provides evidence that GC has a strong predilection to arise on the background of specific molecular features (especially pedHGG_RTK2, pedHGG_A/B, EGFR and BCOR mutations, chromosome 6 rearrangements).

2nd Department of Pediatrics Semmelweis University Budapest Hungary

AbbVie Inc Oncology Development North Chicago IL U S A

Center of Radiology Department of Diagnostic and Interventional Radiology and Neuroradiology Hospital of Fulda Fulda Germany

Department of Neurosciences University of Turin Turin Italy

Department of Onco Hematology Gene and Cell Therapy Bambino Gesù Children's Hospital Rome Italy

Department of Oncology and Children's Research Centre University Children's Hospital Zurich Switzerland

Department of Paediatric Oncology Sir James Spence Institute of Child Health Royal Victoria Infirmary Queen Victoria Road Newcastle upon Tyne UK

Department of Pathology Amsterdam UMC Amsterdam The Netherlands

Department of Pathology and Molecular Medicine 2nd Faculty of Medicine Charles University Prague and University Hospital Motol Prague Czech Republic

Department of Pediatric and Adolescent Medicine University Medical Center Mannheim Medical Faculty Mannheim Heidelberg University Mannheim Germany

Department of Pediatric and Adolescent Oncology Gustave Roussy Université Paris Saclay Villejuif France

Department of Pediatric Hematology and Oncology 2nd Faculty of Medicine Charles University Prague and University Hospital Motol Prague Czech Republic

Department of Pediatric Hematology and Oncology University Hospitals Leuven Belgium

Department of Pediatric Hematology and Oncology University Medical Center Hamburg Eppendorf Hamburg Germany

Department of Pediatric Hematology Oncology and Stem Cell Transplantation University of Regensburg Regensburg Germany

Department of Pediatric Oncology and Hematology Saarland University Homburg Germany

Department of Pediatric Oncology Hematology and Immunology Heidelberg University Hospital Heidelberg Germany

Department of Pediatric Oncology University Hospital Brno and Faculty of Medicine Masaryk University Brno Czech Republic

Department of Pediatrics Clínica Universidad de Navarra Pamplona Spain

Department of Pediatrics Obstetrics and Gynecology Division of Pediatric Hematology and Oncology University Hospital Geneva Geneva Switzerland

Department of Radiation Oncology University of Leipzig Leipzig Germany

Department of Radiological Oncological and Anatomo Pathological Sciences Sapienza University Rome Italy

Department of Radiology and Nuclear Medicine Erasmus MC Rotterdam The Netherlands

Department of Radiotherapy and Radiation Oncology Faculty of Medicine and University Hospital Carl Gustav Carus Technical University Dresden Dresden Germany

Diagnostic and Interventional Neuroradiology Faculty of Medicine University of Augsburg Augsburg Germany

Division of Clinical Neuro Oncology Department of Neurology University Hospital Bonn Bonn Germany

Division of Hematology Oncology and Stem Cell Transplantation Children's Hospital Helsinki University Hospital Helsinki Finland

Division of Hematology Oncology Children's Hospital of Pittsburgh Pittsburgh PA U S A

Division of Molecular Pathology Institute of Cancer Research London UK

Division of Pediatric Glioma Research German Cancer Research Center Heidelberg Germany

Division of Pediatric Hematology and Oncology Department of Pediatrics and Adolescent Medicine Medical University of Graz Graz Austria

Division of Pediatric Hematology and Oncology University Medical Center Göttingen Göttingen Germany

Division of Pediatric Hematology Oncology 1st Department of Pediatrics National and Kapodistrian University of Athens Aghia Sophia Children's Hospital Athens Greece

Division of Pediatric Hematology Oncology Institute of Oncology Istanbul University Istanbul Turkey

Division of Pediatric Neurooncology German Cancer Research Center Heidelberg Germany

GHU Paris Psychiatry and Neuroscience Sainte Anne Hospital Department of Neuropathology Paris France

Health Research Institute of Navarra Pamplona Navarra Spain

Hopp Children's Cancer Center Heidelberg Germany

Institute of Biostatistics and Clinical Research University of Münster Münster Germany

Institute of Diagnostic and Interventional Neuroradiology University of Würzburg Würzburg Germany

Institute of Neuropathology DGNN Brain Tumor Reference Center University of Bonn Medical Center Bonn Germany

National Center for Tumor Diseases Heidelberg Heidelberg Germany

Neuro Oncology Unit IRCSS Istituto Giannina Gaslini Genoa Italy

Neuroradiological Reference Center for the Pediatric Brain Tumor Studies of the German Society of Pediatric Oncology and Hematology University Augsburg Faculty of Medicine Germany

Neurosurgery Unit Bambino Gesù Children's Hospital Rome Italy

Oncological Neuroradiology and Advanced Diagnostics Unit Bambino Gesù Children's Hospital Rome Italy

Pathology Unit Bambino Gesù Children's Hospital Rome Italy

Pediatric and Adolescent Medicine Swabian Children's Cancer Center University Medical Center Augsburg Augsburg Germany

Pediatric Hematology and Oncology Department of Pediatrics University Hospital Würzburg Würzburg Germany

Pediatric Neuro Oncology Pediatric Cancer Center Barcelona Hospital Sant Joan de Deu Barcelona Spain

Pediatric Onco Hematology Department Pediatrics 3 University Hospital of Strasbourg Strasbourg France

Pediatric Oncology Department of Oncology KU Leuven Belgium

Pediatric Oncology Department University Hospital São João Porto Portugal

Pediatric Oncology Great Ormond Street Hospital for Children London UK

Pediatric Oncology Unit Fondazione IRCCS Istituto Nazionale dei Tumori Milano Italy

Princess Máxima Center for Pediatric Oncology Utrecht The Netherlands

Solid Tumor Program Center for the Applied Medical Research Pamplona Navarra Spain

U981 Molecular Predictors and New Targets in Oncology Team Genomics and Oncogenesis of Pediatric Brain Tumors INSERM Gustave Roussy Université Paris Saclay Villejuif France

UMR CNRS 7021 Laboratory of Bioimagery and Pathologies Team tumor signaling and therapeutic targets University of Strasbourg Illkirch France

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc24018987
003      
CZ-PrNML
005      
20241024111207.0
007      
ta
008      
241015s2024 enk f 000 0|eng||
009      
AR
024    7_
$a 10.1093/neuonc/noae080 $2 doi
035    __
$a (PubMed)38717379
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a enk
100    1_
$a Nussbaumer, Gunther $u Division of Pediatric Hematology and Oncology, Department of Pediatrics and Adolescent Medicine, Medical University of Graz, Graz, Austria $1 https://orcid.org/000000030397935X
245    10
$a Gliomatosis cerebri in children: A poor prognostic phenotype of diffuse gliomas with a distinct molecular profile / $c G. Nussbaumer, M. Benesch, Y. Grabovska, A. Mackay, D. Castel, J. Grill, MM. Alonso, M. Antonelli, S. Bailey, JN. Baugh, V. Biassoni, M. Blattner-Johnson, A. Broniscer, A. Carai, GS. Colafati, N. Colditz, S. Corbacioglu, S. Crampsie, N. Entz-Werle, M. Eyrich, LL. Friker, MC. Frühwald, ML. Garrè, NU. Gerber, F. Giangaspero, MJ. Gil-da-Costa, N. Graf, D. Hargrave, P. Hauser, U. Herrlinger, M. Hoffmann, E. Hulleman, E. Izquierdo, S. Jacobs, M. Karremann, A. Kattamis, R. Kebudi, RD. Kortmann, R. Kwiecien, M. Massimino, A. Mastronuzzi, E. Miele, G. Morana, CM. Noack, V. Pentikainen, T. Perwein, SM. Pfister, T. Pietsch, K. Roka, S. Rossi, S. Rutkowski, E. Schiavello, C. Seidel, J. Štěrba, D. Sturm, D. Sumerauer, A. Tacke, S. Temelso, C. Valentini, D. van Vuurden, P. Varlet, SEM. Veldhuijzen van Zanten, M. Vinci, AO. von Bueren, M. Warmuth-Metz, P. Wesseling, M. Wiese, JEA. Wolff, J. Zamecnik, A. Morales La Madrid, B. Bison, GH. Gielen, DTW. Jones, C. Jones, CM. Kramm
520    9_
$a BACKGROUND: The term gliomatosis cerebri (GC), a radiology-defined highly infiltrating diffuse glioma, has been abandoned since molecular GC-associated features could not be established. METHODS: We conducted a multinational retrospective study of 104 children and adolescents with GC providing comprehensive clinical and (epi-)genetic characterization. RESULTS: Median overall survival (OS) was 15.5 months (interquartile range, 10.9-27.7) with a 2-year survival rate of 28%. Histopathological grading correlated significantly with median OS: CNS WHO grade II: 47.8 months (25.2-55.7); grade III: 15.9 months (11.4-26.3); grade IV: 10.4 months (8.8-14.4). By DNA methylation profiling (n = 49), most tumors were classified as pediatric-type diffuse high-grade glioma (pedHGG), H3-/IDH-wild-type (n = 31/49, 63.3%) with enriched subclasses pedHGG_RTK2 (n = 19), pedHGG_A/B (n = 6), and pedHGG_MYCN (n = 5), but only one pedHGG_RTK1 case. Within the pedHGG, H3-/IDH-wild-type subgroup, recurrent alterations in EGFR (n = 10) and BCOR (n = 9) were identified. Additionally, we observed structural aberrations in chromosome 6 in 16/49 tumors (32.7%) across tumor types. In the pedHGG, H3-/IDH-wild-type subgroup TP53 alterations had a significant negative effect on OS. CONCLUSIONS: Contrary to previous studies, our representative pediatric GC study provides evidence that GC has a strong predilection to arise on the background of specific molecular features (especially pedHGG_RTK2, pedHGG_A/B, EGFR and BCOR mutations, chromosome 6 rearrangements).
650    _2
$a lidé $7 D006801
650    _2
$a dítě $7 D002648
650    _2
$a mužské pohlaví $7 D008297
650    12
$a neuroepitelové nádory $x patologie $x genetika $7 D018302
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a mladiství $7 D000293
650    _2
$a retrospektivní studie $7 D012189
650    _2
$a prognóza $7 D011379
650    _2
$a předškolní dítě $7 D002675
650    12
$a nádory mozku $x genetika $x patologie $7 D001932
650    12
$a gliom $x genetika $x patologie $7 D005910
650    _2
$a fenotyp $7 D010641
650    _2
$a míra přežití $7 D015996
650    _2
$a metylace DNA $7 D019175
650    _2
$a kojenec $7 D007223
650    _2
$a nádorové biomarkery $x genetika $7 D014408
650    _2
$a mutace $7 D009154
650    _2
$a následné studie $7 D005500
650    _2
$a stupeň nádoru $7 D060787
655    _2
$a časopisecké články $7 D016428
655    _2
$a multicentrická studie $7 D016448
700    1_
$a Benesch, Martin $u Division of Pediatric Hematology and Oncology, Department of Pediatrics and Adolescent Medicine, Medical University of Graz, Graz, Austria
700    1_
$a Grabovska, Yura $u Division of Molecular Pathology, Institute of Cancer Research, London, UK
700    1_
$a Mackay, Alan $u Division of Molecular Pathology, Institute of Cancer Research, London, UK
700    1_
$a Castel, David $u U981, Molecular Predictors and New Targets in Oncology, Team Genomics and Oncogenesis of Pediatric Brain Tumors, INSERM, Gustave Roussy, Université Paris-Saclay, Villejuif, France $u Department of Pediatric and Adolescent Oncology, Gustave Roussy, Université Paris-Saclay, Villejuif, France
700    1_
$a Grill, Jacques $u U981, Molecular Predictors and New Targets in Oncology, Team Genomics and Oncogenesis of Pediatric Brain Tumors, INSERM, Gustave Roussy, Université Paris-Saclay, Villejuif, France $u Department of Pediatric and Adolescent Oncology, Gustave Roussy, Université Paris-Saclay, Villejuif, France
700    1_
$a Alonso, Marta M $u Department of Pediatrics, Clínica Universidad de Navarra, Pamplona, Spain $u Solid Tumor Program, Center for the Applied Medical Research, Pamplona, Navarra, Spain $u Health Research Institute of Navarra (IdiSNA), Pamplona, Navarra, Spain
700    1_
$a Antonelli, Manila $u Department of Radiological, Oncological and Anatomo-Pathological Sciences, Sapienza University, Rome, Italy
700    1_
$a Bailey, Simon $u Department of Paediatric Oncology, Sir James Spence Institute of Child Health, Royal Victoria Infirmary Queen Victoria Road, Newcastle upon Tyne, UK
700    1_
$a Baugh, Joshua N $u Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands $1 https://orcid.org/0000000172816306
700    1_
$a Biassoni, Veronica $u Pediatric Oncology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Italy
700    1_
$a Blattner-Johnson, Mirjam $u Division of Pediatric Glioma Research, German Cancer Research Center (DKFZ) and German Cancer Consortium (DKTK), Heidelberg, Germany $u Hopp Children's Cancer Center (KiTZ), Heidelberg, Germany
700    1_
$a Broniscer, Alberto $u Division of Hematology-Oncology, Children's Hospital of Pittsburgh, Pittsburgh, PA, U.S.A
700    1_
$a Carai, Andrea $u Neurosurgery Unit, Bambino Gesù Children's Hospital (IRCCS), Rome, Italy $1 https://orcid.org/0000000252037855
700    1_
$a Colafati, Giovanna Stefania $u Oncological Neuroradiology and Advanced Diagnostics Unit, Bambino Gesù Children's Hospital (IRCCS), Rome, Italy
700    1_
$a Colditz, Niclas $u Division of Pediatric Hematology and Oncology, University Medical Center Göttingen, Göttingen, Germany
700    1_
$a Corbacioglu, Selim $u Department of Pediatric Hematology, Oncology and Stem Cell Transplantation, University of Regensburg, Regensburg, Germany
700    1_
$a Crampsie, Shauna $u Division of Molecular Pathology, Institute of Cancer Research, London, UK
700    1_
$a Entz-Werle, Natacha $u UMR CNRS 7021-Laboratory of Bioimagery and Pathologies Team tumor signaling and therapeutic targets, University of Strasbourg, Illkirch, France $u Pediatric Onco-Hematology Department-Pediatrics III, University Hospital of Strasbourg, Strasbourg, France
700    1_
$a Eyrich, Matthias $u Pediatric Hematology and Oncology, Department of Pediatrics, University Hospital Würzburg, Würzburg, Germany
700    1_
$a Friker, Lea L $u Institute of Neuropathology, DGNN Brain Tumor Reference Center, University of Bonn Medical Center, Bonn, Germany
700    1_
$a Frühwald, Michael C $u Pediatric and Adolescent Medicine, Swabian Children's Cancer Center, University Medical Center Augsburg, Augsburg, Germany
700    1_
$a Garrè, Maria Luisa $u Neuro-Oncology Unit, IRCSS Istituto Giannina Gaslini, Genoa, Italy
700    1_
$a Gerber, Nicolas U $u Department of Oncology and Children's Research Centre, University Children's Hospital, Zurich, Switzerland
700    1_
$a Giangaspero, Felice $u Department of Radiological, Oncological and Anatomo-Pathological Sciences, Sapienza University, Rome, Italy
700    1_
$a Gil-da-Costa, Maria J $u Pediatric Oncology Department, University Hospital São João, Porto, Portugal
700    1_
$a Graf, Norbert $u Department of Pediatric Oncology and Hematology, Saarland University, Homburg, Germany
700    1_
$a Hargrave, Darren $u Pediatric Oncology, Great Ormond Street Hospital for Children, London, UK
700    1_
$a Hauser, Peter $u Second Department of Pediatrics, Semmelweis University, Budapest, Hungary
700    1_
$a Herrlinger, Ulrich $u Division of Clinical Neuro-Oncology, Department of Neurology, University Hospital Bonn, Bonn, Germany
700    1_
$a Hoffmann, Marion $u Division of Pediatric Hematology and Oncology, University Medical Center Göttingen, Göttingen, Germany
700    1_
$a Hulleman, Esther $u Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands
700    1_
$a Izquierdo, Elisa $u Division of Molecular Pathology, Institute of Cancer Research, London, UK
700    1_
$a Jacobs, Sandra $u Department of Pediatric Hematology and Oncology, University Hospitals Leuven, Belgium $u Pediatric Oncology, Department of Oncology, KU Leuven, Belgium
700    1_
$a Karremann, Michael $u Department of Pediatric and Adolescent Medicine, University Medical Center Mannheim, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany
700    1_
$a Kattamis, Antonis $u Division of Pediatric Hematology-Oncology, First Department of Pediatrics, National and Kapodistrian University of Athens, "Aghia Sophia" Children's Hospital, Athens, Greece
700    1_
$a Kebudi, Rejin $u Division of Pediatric Hematology-Oncology, Institute of Oncology, Istanbul University, Istanbul, Turkey
700    1_
$a Kortmann, Rolf-Dieter $u Department of Radiation Oncology, University of Leipzig, Leipzig, Germany $1 https://orcid.org/0000000289521819
700    1_
$a Kwiecien, Robert $u Institute of Biostatistics and Clinical Research, University of Münster, Münster, Germany
700    1_
$a Massimino, Maura $u Pediatric Oncology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Italy
700    1_
$a Mastronuzzi, Angela $u Department of Onco-Hematology, Gene and Cell Therapy, Bambino Gesù Children's Hospital (IRCCS), Rome, Italy $1 https://orcid.org/0000000244082373
700    1_
$a Miele, Evelina $u Department of Onco-Hematology, Gene and Cell Therapy, Bambino Gesù Children's Hospital (IRCCS), Rome, Italy
700    1_
$a Morana, Giovanni $u Department of Neurosciences, University of Turin, Turin, Italy $1 https://orcid.org/0000000187075969
700    1_
$a Noack, Claudia M $u Center of Radiology, Department of Diagnostic and Interventional Radiology and Neuroradiology, Hospital of Fulda, Fulda, Germany
700    1_
$a Pentikainen, Virve $u Division of Hematology-Oncology and Stem Cell Transplantation, Children's Hospital, Helsinki University Hospital, Helsinki, Finland
700    1_
$a Perwein, Thomas $u Division of Pediatric Hematology and Oncology, Department of Pediatrics and Adolescent Medicine, Medical University of Graz, Graz, Austria $1 https://orcid.org/0000000169521339
700    1_
$a Pfister, Stefan M $u National Center for Tumor Diseases (NCT) Heidelberg, Heidelberg, Germany $u Department of Pediatric Oncology, Hematology & Immunology, Heidelberg University Hospital, Heidelberg, Germany $u Division of Pediatric Neurooncology, German Cancer Research Center (DKFZ) and German Cancer Consortium (DKTK), Heidelberg, Germany $u Hopp Children's Cancer Center (KiTZ), Heidelberg, Germany
700    1_
$a Pietsch, Torsten $u Institute of Neuropathology, DGNN Brain Tumor Reference Center, University of Bonn Medical Center, Bonn, Germany
700    1_
$a Roka, Kleoniki $u Division of Pediatric Hematology-Oncology, First Department of Pediatrics, National and Kapodistrian University of Athens, "Aghia Sophia" Children's Hospital, Athens, Greece
700    1_
$a Rossi, Sabrina $u Pathology Unit, Bambino Gesù Children's Hospital (IRCCS), Rome, Italy
700    1_
$a Rutkowski, Stefan $u Department of Pediatric Hematology and Oncology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
700    1_
$a Schiavello, Elisabetta $u Pediatric Oncology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Italy
700    1_
$a Seidel, Clemens $u Department of Radiation Oncology, University of Leipzig, Leipzig, Germany
700    1_
$a Štěrba, Jaroslav $u Department of Pediatric Oncology, University Hospital Brno and Faculty of Medicine, Masaryk University, Brno, Czech Republic
700    1_
$a Sturm, Dominik $u Department of Pediatric Oncology, Hematology & Immunology, Heidelberg University Hospital, Heidelberg, Germany $u Division of Pediatric Glioma Research, German Cancer Research Center (DKFZ) and German Cancer Consortium (DKTK), Heidelberg, Germany $u Hopp Children's Cancer Center (KiTZ), Heidelberg, Germany
700    1_
$a Sumerauer, David $u Department of Pediatric Hematology and Oncology, 2nd Faculty of Medicine, Charles University in Prague and University Hospital Motol, Prague, Czech Republic
700    1_
$a Tacke, Anna $u Division of Pediatric Hematology and Oncology, University Medical Center Göttingen, Göttingen, Germany
700    1_
$a Temelso, Sara $u Division of Molecular Pathology, Institute of Cancer Research, London, UK
700    1_
$a Valentini, Chiara $u Department of Radiotherapy and Radiation Oncology, Faculty of Medicine and University Hospital Carl Gustav Carus, Technical University Dresden, Dresden, Germany
700    1_
$a van Vuurden, Dannis $u Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands
700    1_
$a Varlet, Pascale $u GHU-Paris Psychiatry and Neuroscience, Sainte-Anne Hospital, Department of Neuropathology, Paris, France
700    1_
$a Veldhuijzen van Zanten, Sophie E M $u Department of Radiology and Nuclear Medicine, Erasmus MC, Rotterdam, The Netherlands $u Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands
700    1_
$a Vinci, Maria $u Department of Onco-Hematology, Gene and Cell Therapy, Bambino Gesù Children's Hospital (IRCCS), Rome, Italy $1 https://orcid.org/0000000279526771
700    1_
$a von Bueren, André O $u Department of Pediatrics, Obstetrics and Gynecology, Division of Pediatric Hematology and Oncology, University Hospital Geneva, Geneva, Switzerland
700    1_
$a Warmuth-Metz, Monika $u Institute of Diagnostic and Interventional Neuroradiology, University of Würzburg, Würzburg, Germany
700    1_
$a Wesseling, Pieter $u Department of Pathology, Amsterdam UMC, Amsterdam, The Netherlands $u Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands
700    1_
$a Wiese, Maria $u Neurosurgery Unit, Bambino Gesù Children's Hospital (IRCCS), Rome, Italy
700    1_
$a Wolff, Johannes E A $u AbbVie Inc, Oncology Development, North Chicago, IL, U.S.A
700    1_
$a Zamecnik, Josef $u Department of Pathology and Molecular Medicine, 2nd Faculty of Medicine, Charles University in Prague and University Hospital Motol, Prague, Czech Republic
700    1_
$a Morales La Madrid, Andrés $u Pediatric Neuro-Oncology, Pediatric Cancer Center Barcelona, Hospital Sant Joan de Deu, Barcelona, Spain
700    1_
$a Bison, Brigitte $u Neuroradiological Reference Center for the Pediatric Brain Tumor (HIT) Studies of the German Society of Pediatric Oncology and Hematology, University Augsburg, Faculty of Medicine, Germany $u Diagnostic and Interventional Neuroradiology, Faculty of Medicine, University of Augsburg, Augsburg, Germany
700    1_
$a Gielen, Gerrit H $u Institute of Neuropathology, DGNN Brain Tumor Reference Center, University of Bonn Medical Center, Bonn, Germany
700    1_
$a Jones, David T W $u Division of Pediatric Glioma Research, German Cancer Research Center (DKFZ) and German Cancer Consortium (DKTK), Heidelberg, Germany $u Hopp Children's Cancer Center (KiTZ), Heidelberg, Germany
700    1_
$a Jones, Chris $u Division of Molecular Pathology, Institute of Cancer Research, London, UK
700    1_
$a Kramm, Christof M $u Division of Pediatric Hematology and Oncology, University Medical Center Göttingen, Göttingen, Germany
773    0_
$w MED00193498 $t Neuro-oncology $x 1523-5866 $g Roč. 26, č. 9 (2024), s. 1723-1737
856    41
$u https://pubmed.ncbi.nlm.nih.gov/38717379 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y - $z 0
990    __
$a 20241015 $b ABA008
991    __
$a 20241024111201 $b ABA008
999    __
$a ok $b bmc $g 2201678 $s 1230960
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2024 $b 26 $c 9 $d 1723-1737 $e 20240905 $i 1523-5866 $m Neuro-oncology $n Neuro Oncol $x MED00193498
GRA    __
$p German- and Styrian Childhood Cancer Foundation
GRA    __
$p Etoile de Martin
GRA    __
$p Les Boucles du Cœur de la Fondation Carrefour
GRA    __
$a BB-033-00065 $p Necker Imagine Tumor and DNA biobank
GRA    __
$p Rudy A Menon Foundation
GRA    __
$p CRIS Cancer Foundation
GRA    __
$p Ollie Young Foundation
GRA    __
$a C13468/A23536 $p Cancer Research UK $2 United Kingdom
GRA    __
$p Joshua Bembo Project and the AYJ Fund
GRA    __
$p NHS
GRA    __
$p NIHR Great Ormond Street Hospital Biomedical Research Centre
GRA    __
$a PRIMUS/19/MED/06 $p Izas, la Princesa Guisante Foundation
GRA    __
$p Charles University Grant Agency
GRA    __
$p Fondazione Heal
GRA    __
$p Il Coraggio dei Bambini
GRA    __
$p Martina e La Sua Luna
GRA    __
$p Il laboratorio di Chiara
GRA    __
$a NET-2019-12371188 $p Regione Lombardia
GRA    __
$p Italian Ministry of Health
GRA    __
$a NET-2019-12371188 $p Regione Liguria
LZP    __
$a Pubmed-20241015

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...